VIRTUAL SCREENING AND IN VITRO ASSAYS OF LIGANDS WITH ACTIVITY AGAINST DIPEPTIDYL PEPTIDASE-4 (DPP-4) ENZYME

被引：0
|
作者：
Pantaleao, Simone Queiroz [1 ]
Philot, Eric Allison [2 ]
De Paula, Heberth [3 ]
De Sairre, Mirela Ines [1 ]
Lima, Angelica Nakagawa [4 ]
Dos Santos, Raquel Alves [5 ]
Scott, Ana Ligia [2 ]
Honorio, Kathia Maria [1 ]
机构：
[1] Fed Univ ABC, Ctr Sci Nat & Human, Sao Paulo, Brazil
[2] Fed Univ ABC, Ctr Math Comp & Cognit, Sao Paulo, Brazil
[3] Univ Fed Espirito Santo, Ctr Exact Nat & Hlth Sci, Espirito Santo, Brazil
[4] Fed Univ ABC, Ctr Engn Modeling & Appl Social Sci, Sao Paulo, Brazil
[5] Univ Franca, Lab Genet & Mol Biol, Sao Paulo, Brazil
来源：
BIOPHYSICAL REVIEWS | 2021年 / 13卷 / 06期
关键词：
Diabetes; DPP-4; Drug discovery;
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
CD.21
引用
收藏
页码：1332 / 1332
页数：1
相关论文
共 50 条
  • [31] INDUCTION OF TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES (TIMPs) IN NASH AND REGULATION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) BY TIMPs
    Lin, Huey
    Liu, Xunyu
    Zhu, Lixin
    Baker, Susan
    Baker, Robert
    Lee, Techung
    HEPATOLOGY, 2020, 72 : 1051 - 1052
  • [32] A META-ANALYSIS OF EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-4 [DPP-4] INHIBITORS IN TYPE 2 DIABETES
    Park, H.
    Park, C.
    Kim, Y.
    Rascati, K. L.
    VALUE IN HEALTH, 2012, 15 (04) : A172 - A172
  • [33] Factors contributing to the adverse drug reactions associated with the dipeptidyl peptidase-4 (DPP-4) inhibitors: A scoping review
    Reghunath, Swetha R.
    Rashid, Muhammed
    Chandran, Viji Pulikkel
    Thunga, Girish
    Shivashankar, K. N.
    Acharya, Leelavathi D.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (07)
  • [34] Exploring Hepatic Safety of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Vildagliptin in a Real-World Setting
    Williams, Rachael
    Kothny, Wolfgang
    Serban, Carmen
    Paldanius, Paivi M.
    Schlienger, Raymond
    DIABETES, 2018, 67
  • [35] Activation of Transient Receptor Potential Channel Vanilloid 4 by DPP-4 (Dipeptidyl Peptidase-4) Inhibitor Vildagliptin Protects Against Diabetic Endothelial Dysfunction
    Gao, Peng
    Li, Li
    Wei, Xiao
    Wang, Miao
    Hong, Yangning
    Wu, Hao
    Shen, Yanjia
    Ma, Tianyi
    Wei, Xing
    Zhang, Qin
    Fang, Xia
    Wang, Lijuan
    Yan, Zhencheng
    Du, Guan-Hua
    Zheng, Hongting
    Yang, Gangyi
    Liu, Daoyan
    Zhu, Zhiming
    HYPERTENSION, 2020, 75 (01) : 150 - 162
  • [36] COSTS FOR DIABETIC PATIENTS RECEIVING DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS IN US MEDICARE AND COMMERCIAL INSURANCE PLANS
    Rascati, K. L.
    Worley, K.
    Everhart, D.
    Meah, Y.
    VALUE IN HEALTH, 2015, 18 (07) : A601 - A602
  • [37] Acute onset of rheumatoid arthritis associated with administration of a dipeptidyl peptidase-4 (DPP-4) inhibitor to patients with diabetes mellitus
    Sasaki T.
    Hiki Y.
    Nagumo S.
    Ikeda R.
    Kimura H.
    Yamashiro K.
    Gojo A.
    Saito T.
    Tomita Y.
    Utsunomiya K.
    Diabetology International, 2010, 1 (2) : 90 - 92
  • [38] Binding to Dipeptidyl Peptidase-4 Determines the Disposition of Linagliptin (BI 1356) - Investigations in DPP-4 Deficient and Wildtype Rats
    Retlich, Silke
    Withopf, Barbara
    Greischel, Andreas
    Staab, Alexander
    Jaehde, Ulrich
    Fuchs, Holger
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2009, 30 (08) : 422 - 436
  • [39] Dipeptidyl peptidase 4 (DPP-4) as a target for type 2 diabetes.
    Hughes, TE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U944 - U944
  • [40] The Inhibitory Effects of New Zealand Pine Bark (Enzogenol®) on α-Amylase, α-Glucosidase, and Dipeptidyl Peptidase-4 (DPP-4) Enzymes
    Lim, Wen Xin Janice
    Gammon, Cheryl S.
    von Hurst, Pamela
    Chepulis, Lynne
    Page, Rachel A.
    NUTRIENTS, 2022, 14 (08)
12345